Protective effect of polydatin against lipopolysaccharide-induced myocardial injury

Di Yi Jun Yi Da Xue Xue Bao. 2003 Apr;23(4):364-6.

Abstract

Objective: To observe the effect of lipopolysaccharide (LPS) on actin cytoskeleton of rat cardiac myocytes and the intervention effect of polydatin against this effect.

Methods: Rat cardiac myocytes were isolated from newborn SD rats (3 days old) and cultured in vitro, which were then divided into control group (treated with D-Hank's solution for 30 min), polydatin group (with 0.2 mmol/L polydatin treatment for 10 min), LPS group (with 100 ng/ml LPS stimulation for 30 min), and LPS/polydatin group (with 100 ng/ml LPS stimulation for 30 min followed by incubation with 0.2 mmol/L polydatin for 10 min). When the treatments were completed, the cells were analyzed for myocardial F-actin by immunofluorescent staining.

Results: In the control group, F-actin was localized in the cortex of cardiac myocytes and the cells were filled with F-actin organized into reticular structures. After LPS stimulation, the staining for F-actin was faint or even invisible in the cortex, with the formation of stress fibers observed in the cells, which disappeared upon the 10-min polydatin treatment and the F-actin resumed normal arrangement. No obvious difference was found between the control and polydatin groups.

Conclusion: LPS may directly induce stress fiber formation, therefore cause damages to rat cardiac myocytes, which can be reverted by polydatin through the mechanism of participating in the F-actin organization.

MeSH terms

  • Animals
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / prevention & control
  • Drug Interactions
  • Glucosides / pharmacology*
  • Glucosides / therapeutic use
  • Heart / drug effects
  • Lipopolysaccharides / pharmacology*
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / physiology
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Stilbenes / pharmacology*
  • Stilbenes / therapeutic use
  • Stress Fibers / drug effects*

Substances

  • Glucosides
  • Lipopolysaccharides
  • Protective Agents
  • Stilbenes
  • polydatin